Skip to main content

Table 1 Association between AGK expression and the clinicopathological features of RCC

From: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

Feature No. of patients AGK expression P-value
Low High
Gender
 Male 81 (67.5%) 41 (50.6%) 40 (49.4%) 1.000
 Female 39 (32.5%) 19 (48.7%) 20 (51.3%)
Age(years)
 < 50 68 (56.7%) 32 (47.1%) 36 (52.9%) 0.581
 ≥ 50 52 (43.3%) 28 (53.8%) 24 (46.2%)  
Family history of cancer
 Yes 10 (8.3%) 4 (40.0%) 6 (60.0%) 0.743
 No 110 (91.7%) 56 (50.9%) 54 (49.1%)  
Clinical stage
 I-II 83 (69.2%) 51 (61.4%) 32 (38.6%) < 0.001
 III-IV 37 (30.8%) 9 (24.3%) 28 (75.7%)  
Pathological classification
 Renal clear cell carcinoma 116 (96.7%) 57 (49.1%) 59 (50.9%) 0.619
 Others 4 (3.3%) 3 (75.0%) 1 (25.0%)  
Fuhrman classification
 I-II 96 (80.0%) 54 (56.3%) 42 (43.7%) 0.011
 III-IV 24 (20.0%) 6 (25.0%) 18 (75.0%)  
Recurrence with metastasis
 Absent 93 (77.5%) 57 (61.3%) 36 (38.7%) < 0.001
 Present 27 (22.5%) 8 (11.1%) 19 (88.9%)  
Vital status
 Alive 97 (80.8%) 58 (59.8%) 39 (40.2%) < 0.001
 Dead 23 (19.2%) 2 (8.7%) 21 (91.3%)